| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/30/2014 | CA2772912C Stable formulation of factor viii |
| 12/30/2014 | CA2675847C Pegylated a.beta. fab |
| 12/30/2014 | CA2604835C Compositions comprising probiotic and sweetener components |
| 12/30/2014 | CA2581605C Enteral nutrient |
| 12/25/2014 | US20140378831 Multifunctional nanomaterials for the treatment of cancer |
| 12/25/2014 | US20140378673 Prodrug using nitroimidazole |
| 12/25/2014 | US20140378669 Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid |
| 12/25/2014 | US20140378668 Tyrosine Bioconjugation through Aqueous Ene-Like Reactions |
| 12/25/2014 | US20140378666 Dual specificity antibodies and methods of making and using |
| 12/25/2014 | US20140378656 Soluble tcr molecules and methods of use |
| 12/25/2014 | US20140378654 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 12/25/2014 | US20140378557 Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans |
| 12/25/2014 | US20140378556 Fucose-containing bacterial biopolymer |
| 12/25/2014 | US20140378555 Facial treatment device |
| 12/25/2014 | US20140378549 Implantation compositions for use in tissue augmentation |
| 12/25/2014 | US20140378543 Methods of producing and using nutritional and pharmaceutical compositions that include one or more active substances |
| 12/25/2014 | US20140378542 Cocrystals of dimethyl fumarate |
| 12/25/2014 | US20140378532 Glycogen-based cationic polymers |
| 12/25/2014 | US20140378517 Formulations of enzalutamide |
| 12/25/2014 | US20140378498 Tamper Resistant Composition Comprising Hydrocodone And Acetaminophen For Rapid Onset And Extended Duration Of Analgesia |
| 12/25/2014 | US20140378497 Sublingual and buccal film compositions |
| 12/25/2014 | US20140378490 Formulations of Phenyl Uracil Compounds |
| 12/25/2014 | US20140378427 Cabazitaxel-platinum nanoparticles and methods of using same |
| 12/25/2014 | US20140378414 Cyclodextrin-based polymers for therapeutic delivery |
| 12/25/2014 | US20140378410 Composition for inhibiting after-cataract and method for preparing same |
| 12/25/2014 | US20140378407 Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis |
| 12/25/2014 | US20140378404 Treatment of Patients Suffering from Cancer |
| 12/25/2014 | US20140378401 Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations |
| 12/25/2014 | US20140378394 Methods for treating erectile dysfunction in patients with insulin-dependent diabetes |
| 12/25/2014 | US20140378393 Stable Formulations of Linaclotide |
| 12/25/2014 | US20140378391 Ophthalmic Lipophilic Drug Delivery Vehicle Formulations |
| 12/25/2014 | US20140378381 Stabilized glucagon nanoemulsions |
| 12/25/2014 | US20140377838 Stabilization of biomolecules using sugar polymers |
| 12/25/2014 | US20140377369 Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivatives |
| 12/25/2014 | US20140377366 Biodegradable polymers for delivery of therapeutic agents |
| 12/25/2014 | US20140377364 Active ingredient delivery system |
| 12/25/2014 | US20140377361 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
| 12/25/2014 | US20140377357 Poloxamer Based Inhalation Composition |
| 12/25/2014 | US20140377356 Inhalation Composition for Treating Respiratory Tract Infections |
| 12/25/2014 | US20140377355 Levofloxacin Inhalation Composition |
| 12/25/2014 | US20140377350 Bilayer tablet formulations of flurbiprofen and glucosamin |
| 12/25/2014 | US20140377343 Formulations of flurbiprofen and diacerein |
| 12/25/2014 | US20140377342 Wafer and capsule formulations with enhanced dissolution rates for fenofibrate |
| 12/25/2014 | US20140377336 Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma |
| 12/25/2014 | US20140377334 In vivo targeting of cells with ligand-conjugated particles |
| 12/25/2014 | US20140377332 Nanoshells on polymers |
| 12/25/2014 | US20140377322 Multi-layered structure for drug reservoir and drug eluting stent including the same |
| 12/25/2014 | US20140377319 Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid |
| 12/25/2014 | US20140377313 Formulation for Providing an Enteric Coating Material |
| 12/25/2014 | US20140377302 Immunogenic composition |
| 12/25/2014 | US20140377290 Site-specific glp-2 conjugate using an immunoglobulin fragment |
| 12/25/2014 | US20140377287 Anti-trop-2 antibody-drug conjugates and uses thereof |
| 12/25/2014 | US20140377264 Polypeptide Formulation |
| 12/25/2014 | US20140377263 Let-7 microrna and mimetics thereof as therapeutics for cancer |
| 12/25/2014 | US20140377251 Formulation for anti-alpha4beta7 antibody |
| 12/25/2014 | US20140377250 Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency |
| 12/25/2014 | US20140377244 Stable formulations for cns delivery of arylsulfatase a |
| 12/25/2014 | US20140377243 Cell-penetrating fusion protein for regenerating or proliferating stem cell |
| 12/25/2014 | US20140377242 Coenzyme q10-containing composition for oral ingestion |
| 12/25/2014 | US20140377215 Delivery of therapeutic agents by a collagen binding protein |
| 12/25/2014 | US20140377212 Conformations of divergent peptides with mineral binding affinity |
| 12/25/2014 | US20140377210 Artificial tear compositions |
| 12/25/2014 | US20140377209 Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof |
| 12/25/2014 | US20140377195 Polymer composition containing natural bioactive principles for use in pharmaceutical and cosmetic formulations |
| 12/25/2014 | US20140377184 Methods and Compositions Related to Targeting Tumors and Wounds |
| 12/25/2014 | US20140377181 Molecules with extended half-lives, compositions and uses thereof |
| 12/25/2014 | US20140377179 Compositions and methods for delivering inhibitory oligonucleotides |
| 12/25/2014 | US20140377176 Functionalised silicon nanoparticles |
| 12/25/2014 | US20140377175 Chemically-linked nanoparticles |
| 12/25/2014 | US20140377174 Method for preparing cell targeting conjugates, and the complexes obtained |
| 12/25/2014 | US20140377173 Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer |
| 12/25/2014 | US20140377168 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin |
| 12/24/2014 | CN204033817U 一种预混合型中药水蜜丸剂 A ready-mixed type of medicine water pill agent |
| 12/24/2014 | CN104245801A 基于葫芦脲的水凝胶 Cucurbituril based hydrogels |
| 12/24/2014 | CN104245800A 新苯聚羧酸化合物 The new compound benzene polycarboxylate |
| 12/24/2014 | CN104245794A α-氨基脒聚合物及其用途 α- amino amidine polymers and their use |
| 12/24/2014 | CN104244989A 含有新颖前药的分子组合物和其用途 Molecular composition containing the novel prodrugs and their uses |
| 12/24/2014 | CN104244988A 结合治疗活性剂的聚合物、其制备方法以及其用途 Polymer active agent combination therapy, their preparation and their use |
| 12/24/2014 | CN104244987A 新型寡核苷酸缀合物及其应用 The new oligonucleotide conjugates and its application |
| 12/24/2014 | CN104244986A 可控释的药物递送缀合物及其应用 Controlled release drug delivery conjugates and their application |
| 12/24/2014 | CN104244985A 生物材料的稳定化组合物 Stabilized composition biomaterials |
| 12/24/2014 | CN104244984A 用于治疗剂的方法和组合物 A method for therapeutic agents and compositions |
| 12/24/2014 | CN104244983A 控制释放组合物及其使用方法 Controlled release composition and method of use |
| 12/24/2014 | CN104244936A 镇痛剂 Analgesics |
| 12/24/2014 | CN104244930A 口腔崩解片及其制造方法 Orally disintegrating tablets and its manufacturing method |
| 12/24/2014 | CN104244928A 磁性纳米颗粒-SAMiRNA复合物及其制备方法 Magnetic nanoparticles -SAMiRNA compound and preparation method |
| 12/24/2014 | CN104244926A 作为强效的hcv 抑制剂的稳定的药物制剂 Stable pharmaceutical formulations as a potent inhibitor of hcv |
| 12/24/2014 | CN104231288A 一种高强度胶原凝胶及其制备方法 A high-strength collagen gel and its preparation method |
| 12/24/2014 | CN104231265A 脂肪烃基接枝的低分子量聚乙烯亚胺、制备方法及应用 Low molecular weight aliphatic hydrocarbon group grafted polyethylenimine, preparation method and application |
| 12/24/2014 | CN104231255A 松萝酸脂肪醇聚氧乙烯醚络合物 Usnic acid, fatty alcohol ethoxylates complex |
| 12/24/2014 | CN104231246A 普鲁兰多糖为主链的梳状两亲性聚合物、合成工艺及其应用 Comb pullulan-based chain amphiphilic polymers, synthetic process and application |
| 12/24/2014 | CN104231193A 一种pH与氧化还原双敏感的层交联纳米粒及其制备方法和应用 One pH and redox-sensitive layer of the double cross-linked nanoparticles and its preparation method and application |
| 12/24/2014 | CN104231155A 胆固醇修饰两亲性pH响应刷状共聚物和制备及其胶束 Cholesterol-modified amphiphilic pH response brush copolymer micelles and the preparation and |
| 12/24/2014 | CN104231137A 一种聚合物包埋疏水性抗肿瘤药物纳米复合微球的制备方法 A polymer-embedded hydrophobic anticancer drugs nanocomposite microspheres prepared |
| 12/24/2014 | CN104231091A 羟丙基甲基纤维素邻苯二甲酸酯的制备方法 Preparation hydroxypropylmethylcellulose phthalate |
| 12/24/2014 | CN104231087A 具有阻断新生血管形成功能的多肽化合物 Has blocked angiogenesis polypeptide compound function |
| 12/24/2014 | CN104231085A 靶向特异性补体系统抑制剂、其制备方法及应用 Targeting specific inhibitor of the complement system, its preparation method and application |
| 12/24/2014 | CN104231082A 用于治疗骨疾病和病症的针对rank-l的氨基酸序列以及包括其的多肽 For rank-l amino acid sequence for the treatment of bone diseases and disorders as well as a polypeptide including |
| 12/24/2014 | CN104231050A 一种抑制肿瘤转移和治疗白血病的多肽和多肽复合物、其制备方法及其应用 A method of inhibiting peptides and peptide complexes metastasis and treatment of leukemia, their preparation and their use |
| 12/24/2014 | CN104231047A 水溶性靶向激活的紫杉醇衍生物及其制备和用途 Water-soluble taxol derivatives and active targeting preparation and use |